IQVIA is a diagnostics & research business based in the US. IQVIA shares (IQV) are listed on the NYSE and all prices are listed in US Dollars.
Its last market close was $193.44 – a decrease of 7.06% over the previous week. IQVIA employs 88,000 staff and has a trailing 12-month revenue of around $15.3 billion.Our top picks for where to buy IQVIA stock
How to buy IQVIA stock
- Choose a stock trading platform. Compare investment platforms.
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – IQV. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy IQVIA stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Note: The dollar amounts in the table below are in Canadian dollars.
Finder Score for stock trading platforms
To make comparing even easier we came up with the Finder Score. Trading costs, account fees and features across 10+ stock trading platforms and apps are all weighted and scaled to produce a score out of 10. The higher the score the better the platform - simple.
IQVIA stock price (NYSE: IQV)
Use our graph to track the performance of IQV stocks over time.IQVIA stocks at a glance
Latest market close | $193.44 |
---|---|
52-week range | $187.62 - $261.73 |
50-day moving average | $200.85 |
200-day moving average | $220.35 |
Wall St. target price | $247.95 |
PE ratio | 26.14 |
Dividend yield | N/A |
Earnings per share (TTM) | $7.50 |
Is it a good time to buy IQVIA stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
IQVIA price performance over time
Historical closes compared with the close of $196.05 from 2025-02-13
1 week (2025-02-07) | -5.81% |
---|---|
1 month (2025-01-15) | -0.03% |
3 months (2024-11-15) | 1.75% |
6 months (2024-08-15) | -18.62% |
1 year (2024-02-15) | -18.81% |
---|---|
2 years (2023-02-15) | -13.65% |
3 years (2022-02-15) | 228.64 |
5 years (2020-02-14) | 19.31% |
Is IQVIA stock undervalued or overvalued?
Valuing IQVIA stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of IQVIA's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
IQVIA's P/E ratio
IQVIA's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 26x. In other words, IQVIA shares trade at around 26x recent earnings.
That's comparable to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29).
IQVIA's PEG ratio
IQVIA's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.0557. A low ratio can be interpreted as meaning the stocks offer better value, while a higher ratio can be interpreted as meaning the stocks offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into IQVIA's future profitability. By accounting for growth, it could also help you if you're comparing the stock prices of multiple high-growth companies.
IQVIA's EBITDA
IQVIA's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $2.8 billion.
The EBITDA is a measure of a IQVIA's overall financial performance and is widely used to measure a its profitability.
IQVIA financials
Revenue TTM | $15.3 billion |
---|---|
Operating margin TTM | 14.84% |
Gross profit TTM | $5.4 billion |
Return on assets TTM | 5.11% |
Return on equity TTM | 22% |
Profit margin | 9.17% |
Book value | $38.37 |
Market Capitalization | $34.5 billion |
TTM: trailing 12 months
IQVIA stock dividends
We're not expecting IQVIA to pay a dividend over the next 12 months.
IQVIA stock price volatility
Over the last 12 months, IQVIA's stocks have ranged in value from as little as $187.62 up to $261.73. A popular way to gauge a stock's volatility is its "beta."
Beta is a measure of a stocks volatility in relation to the market. The market (NYSE average) beta is 1, while IQVIA's is 1.513. This would suggest that IQVIA's stocks are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
IQVIA overview
IQVIA Holdings Inc. engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; strategic planning and design services; and patient and site centric solutions, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services.
Frequently asked questions
What percentage of IQVIA is owned by insiders or institutions?Currently 0.925% of IQVIA stocks are held by insiders and 93.319% by institutions. How many people work for IQVIA?
Latest data suggests 88,000 work at IQVIA. When does the fiscal year end for IQVIA?
IQVIA's fiscal year ends in December. Where is IQVIA based?
IQVIA's address is: 2400 Ellis Road, Durham, NC, United States, 27703 What is IQVIA's ISIN number?
IQVIA's international securities identification number is: US46266C1053 What is IQVIA's CUSIP number?
IQVIA's Committee on Uniform Securities Identification Procedures number is: 74876Y101
More on investing

What are the best stocks for beginners with little money to invest?
Want to dive into investing but don’t have much to spend? Take a look at these types of stocks.
Read more…
Meme stocks: What they are and examples of popular stocks
Meme stocks can produce large gains in short periods, but the stocks are volatile.
Read more…
How do ETFs work?
Your guide to how ETFs work and whether this type of investment is right for you.
Read more…More guides on Finder
-
How to buy spot Ethereum ETFs in Canada
Check out a list of Ethereum ETFs in Canada and the US, and find out how to buy an ETH ETF in Canada.
-
What are the best stocks for beginners with little money to invest?
Want to dive into investing but don’t have much to spend? Take a look at these types of stocks.
-
Meme stocks: What they are and examples of popular stocks
Meme stocks can produce large gains in short periods, but the stocks are volatile.
-
Best renewable energy stocks
These are the best renewable energy stocks to buy now in Canada.
-
Best stocks to buy right now in Canada
Finder’s unique algorithm found the 20 best TSX stocks to buy right now.
-
4 Best US ETFs for 2025
Looing for the best US ETF? Explore the best US ETFs, including top US dividend and Nasdaq funds.
-
10 best stock trading platforms and apps in Canada for 2025
Whether you’re a new or experienced investor, these are the best stock trading platforms and apps in Canada.
-
How to invest in the S&P 500 in Canada
Find out how to invest in the S&P 500 in Canada—one of the world’s most popular stock indices—to diversify your portfolio.
-
How to trade options in Canada
What is options trading and are options better than stocks? Learn how options trading in Canada works.
-
Interactive Brokers review
Interactive Brokers makes it easy for Canadian investors to access global exchanges with competitive rates and fees.